MAPT and Alzheimer disease: Unfortunately, the weak correlation between CSF and plasma Tau together with the wide variability of Aβ levels reported in blood confer to these main hallmarks of AD a poor predictive and diagnosis value, suggesting the need for more accurate AD biomarkers.